Collegium Pharmaceutical's Series B Round

Collegium Pharmaceutical raised a round of funding on February 22, 2012.

Collegium Pharmaceutical is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chron…

Articles about Collegium Pharmaceutical's Series B Round: